Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Active-controlled, Single-blind, 2-Period, 12-Sequence Crossover Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Pemafibrate in Patients With Dyslipidemia
Conditions
Interventions
K-877 IR 0.2 mg/day
K-877 CR 0.4 mg/day
+1 more
Locations
1
Japan
Medical Corporation Heishinkai OPHAC Hospital
Osaka, Japan
Start Date
September 13, 2019
Primary Completion Date
December 24, 2019
Completion Date
December 24, 2019
Last Updated
October 6, 2025
NCT06380322
NCT06568471
NCT05845424
NCT06322056
NCT06578676
NCT06293417
Lead Sponsor
Kowa Company, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions